0 likes | 13 Views
Analysis of Extracorporeal Membrane Oxygenation Machines Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~7% during 2024-2036 and Attain ~USD 30 Billion by 2036
E N D
Analysis of Extracorporeal Membrane Oxygenation Machines Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~7% during 2024-2036 and Attain ~USD 30 Billion by 2036 Research Nester assesses the growth and market size of global extracorporeal membrane oxygenation machines market which is anticipated to be on account of the increasing demand from end-use industries and increasing demand for healthcare sector. New York – January 8, 2024 - Research Nester’s recent market research analysis on “Extracorporeal Membrane Oxygenation Machines Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global extracorporeal membrane oxygenation machines market in terms of market segmentation by type, end user, and by region. Increasing Aging Population and Critical Care Needs to Promote Global Market Share of Extracorporeal Membrane Oxygenation Machines The growing aging population worldwide is contributing significantly to the demand for ECMO machines. Elderly individuals often experience a higher incidence of cardiac and respiratory issues, necessitating advanced life support systems. As the proportion of the elderly population continues to rise, there is a corresponding increase in the need for ECMO therapy in critical care settings. A demographic study by the United Nations indicates that the global population aged 60 and above is expected to reach 2.1 billion by 2050. Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-5525
Some of the major growth factors and challenges that are associated with the growth of the global extracorporeal membrane oxygenation machines market are: Growth Drivers: • Increasing Advancements Driving Innovation • Growing Health Events and Preparedness Challenges: There is a lack of comprehensive awareness and training among healthcare professionals regarding the optimal utilization of ECMO therapy. As ECMO machines involve complex technology and require specialized skills for proper management, inadequate training can lead to suboptimal use and potential complications. The limited expertise in ECMO technology may hinder its integration into routine clinical practice, affecting market growth. Efforts to enhance education and training programs for healthcare professionals are crucial to overcoming this challenge. The veno-arterial segment is to garner a highest revenue by the end of 2036 by growing at a significant CAGR over the forecast period. The Veno- Arterial (VA) ECMO segment thrives on its ability to provide comprehensive life support in scenarios involving both cardiac and respiratory failure. Cardiac emergencies, such as acute myocardial infarction or post-cardiotomy shock, demand immediate intervention to maintain perfusion. VA ECMO serves as a crucial tool in stabilizing patients during these critical moments. Request for customization @ https://www.researchnester.com/customized-reports-5525
By region, the Europe extracorporeal membrane oxygenation machines market is to generate a notable revenue by the end of 2036. Extracorporeal Membrane Oxygenation (ECMO) Machines Market refers to the global industry involved in the manufacturing, distribution, and utilization of medical devices designed to provide temporary life support to patients experiencing severe respiratory or cardiac failure. ECMO machines are extracorporeal life support systems that function outside the body, temporarily taking over the duties of the heart and lungs to oxygenate the blood and remove carbon dioxide. Key components of ECMO systems include a pump to circulate blood, an oxygenator to facilitate gas exchange, and tubing to connect the patient to the machine. ECMO is typically employed in critical care settings, such as intensive care units (ICUs) and operating rooms, and is used as a bridge to recovery for patients with conditions like acute respiratory distress syndrome (ARDS), cardiogenic shock, or those undergoing complex cardiac surgeries. This report also provides the existing competitive scenario of some of the key players of the global extracorporeal membrane oxygenation machines market which includes company profiling of Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG (Acquired by Fresenius Medical Care AG & Co. KGaA), Microport Scientific Corporation,and others. Access our detailed report @ https://www.researchnester.com/reports/extracorporeal- membrane-oxygenation-machine-market/5525 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and
investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919